首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   673906篇
  免费   34186篇
  国内免费   826篇
耳鼻咽喉   8598篇
儿科学   20997篇
妇产科学   15893篇
基础医学   113137篇
口腔科学   17382篇
临床医学   56923篇
内科学   126779篇
皮肤病学   15920篇
神经病学   45932篇
特种医学   23102篇
外国民族医学   54篇
外科学   94753篇
综合类   8294篇
现状与发展   2篇
一般理论   128篇
预防医学   56416篇
眼科学   15773篇
药学   52663篇
  1篇
中国医学   1714篇
肿瘤学   34457篇
  2021年   6176篇
  2019年   6501篇
  2018年   10218篇
  2017年   6918篇
  2016年   7627篇
  2015年   8465篇
  2014年   10565篇
  2013年   15735篇
  2012年   24642篇
  2011年   26996篇
  2010年   14707篇
  2009年   12284篇
  2008年   23542篇
  2007年   25805篇
  2006年   24955篇
  2005年   23953篇
  2004年   22934篇
  2003年   21911篇
  2002年   21091篇
  2001年   26543篇
  2000年   27485篇
  1999年   22351篇
  1998年   5848篇
  1997年   4754篇
  1996年   4798篇
  1992年   16280篇
  1991年   17516篇
  1990年   17607篇
  1989年   17001篇
  1988年   15662篇
  1987年   15442篇
  1986年   14465篇
  1985年   13921篇
  1984年   10287篇
  1983年   8757篇
  1982年   4572篇
  1979年   9935篇
  1978年   7031篇
  1977年   5800篇
  1976年   6124篇
  1975年   7333篇
  1974年   8369篇
  1973年   8123篇
  1972年   7533篇
  1971年   7203篇
  1970年   6724篇
  1969年   6349篇
  1968年   6083篇
  1967年   5443篇
  1966年   4714篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
Gangliocytic paragangliomas are rare tumors that almost exclusively occur within the second portion of the duodenum. Although these tumors generally have a benign clinical course, they have the potential to recur or metastasize to regional lymph nodes. The case report presented here describes a 57-year-old female patient with melena, progressive asthenia, anemia, and a mass in the second-third portion of the duodenum that was treated by local excision. The patient was diagnosed with a friable bleeding tumor. The histologic analysis showed that the tumor was a 4 cm gangliocytic paraganglioma without a malignant cell pattern. In the absence of local invasion or distant metastasis, endoscopic resection represents a feasible, curative therapy. Although endoscopic polypectomy is currently considered the treatment of choice, it is not recommended if the size of the tumor is > 3 cm and/or there is active or recent bleeding. Patients diagnosed with a gangliocytic paraganglioma should be closely followed-up for possible local recurrence.  相似文献   
33.
34.
35.
36.
Evidence continues to grow on potential environmental health hazards associated with engineered nanomaterials (ENMs). While the geno- and cytotoxic effects of ENMs have been investigated, their potential to target the epigenome remains largely unknown. The aim of this study is two-fold: 1) determining whether or not industry relevant ENMs can affect the epigenome in vivo and 2) validating a recently developed in vitro epigenetic screening platform for inhaled ENMs. Laser printer-emitted engineered nanoparticles (PEPs) released from nano-enabled toners during consumer use and copper oxide (CuO) were chosen since these particles induced significant epigenetic changes in a recent in vitro companion study. In this study, the epigenetic alterations in lung tissue, alveolar macrophages and peripheral blood from intratracheally instilled mice were evaluated. The methylation of global DNA and transposable elements (TEs), the expression of the DNA methylation machinery and TEs, in addition to general toxicological effects in the lung were assessed. CuO exhibited higher cell-damaging potential to the lung, while PEPs showed a greater ability to target the epigenome. Alterations in the methylation status of global DNA and TEs, and expression of TEs and DNA machinery in mouse lung were observed after exposure to CuO and PEPs. Additionally, epigenetic changes were detected in the peripheral blood after PEPs exposure. Altogether, CuO and PEPs can induce epigenetic alterations in a mouse experimental model, which in turn confirms that the recently developed in vitro epigenetic platform using macrophage and epithelial cell lines can be successfully utilized in the epigenetic screening of ENMs.  相似文献   
37.
38.
Guidelines and consensus on the management of patients with acne aim to give evidence-based, expert-group recommendations. This review compares current guidelines and consensus articles to provide a compilation of recommendations on the treatment of acne with oral isotretinoin. Ten common, relevant, clinical questions are addressed, based on published recommendations, including the indications of isotretinoin, the proposed daily dose, the cumulative isotretinoin dose and the laboratory monitoring needed. Recommendations on special considerations are also addressed, including the timing of procedures and the question of an association of depression or inflammatory bowel disease with isotretinoin. A major limitation is the use of different classification systems for acne across guidelines. The recommended daily dose ranges from 0.3 to 0.5 mg/kg in the European guidelines to up to 1 mg/kg in the US guidelines. A specific duration of treatment of at least 6 months is only recommended in the European guidelines. All guidelines report the need of strict pregnancy prevention measures. The European, French and US guidelines recommend to monitor for symptoms of depression. Important clinical questions that are inconsistently addressed in guidelines include the age indication, the recommendation for a cumulative dose, the timing of procedures, the association of isotretinoin with IBD, the recommendation for preventing acne flares and for appropriate laboratory monitoring. These topics should be clearly included in the recommendations of guidelines as they are often raised in everyday clinical practice.  相似文献   
39.
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号